TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RNTX

Rein Therapeutics Inc

Healthcare · Biotechnology

0.7947$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Rein Therapeutics Inc (RNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 24 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RNTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.9 22 53 30 26 16 48 22 106 69 24
4.0 21 52 22 20 16 48 22 18 14 4.3
3.8 21 12 11 5.3 7.0 3.6 5.2 17 13 3.2
3.8 21 51 21 18 14 46 21 17 13 3.2
0.0 6.3 6.3 6.3
79 49 14
100 134 4.9 11 10 4.2 4.6 3.4 99 15 7.2
2.5 4.1 4.9 5.4 5.8 4.0 4.5 3.4 4.4 5.7 6.2
0.4 0.2 0.1 0.0 0.0
0.6 2.0 1.6 1.7 1.5 1.6 1.2 1.7 1.2 0.9 4.0
0.2
-94 -112 48 20 16 12 44 19 6.9 54 17
-96 -114 -137 -168 -198 -219 -245 -273 -289 -351 -401
17 4.4 4.5 4.6 18 25

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?